• Home>
  • Stocks>
  • Glenmark Pharmaceuticals Ltd Share Price
Glenmark Pharmaceuticals Ltd share price logo

Glenmark Pharmaceuticals Ltd Share Price

NSE: GLENMARK

BSE: 532296

Mid Cap

Healthcare Sector

₹2004.40

85.60

(4.46%) ▲

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Option Chain

Advanced Chart

🔔 Rating Alert

HSBC maintains buy rating on Glenmark Pharmaceuticals with a target price of ₹2,380, citing growth drivers including FDA approvals and debt reduction.

Glenmark Pharmaceuticals Ltd Stock Performance

as on September 3, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹1,929
    ₹2,009
    downward going graph

    3.76%

    Downside

    0.23%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,275.5
    ₹2,284.8
    downward going graph

    36.36%

    Downside

    13.99%

    Upside

    downward going graph

Glenmark Pharmaceuticals Ltd share price movements today

Previous Close
₹1,918.80
Open
₹1,938.00
Volume
13.82L
Upper Circuit
₹2,110.60
Lower Circuit
₹1,727.00
Day's Low - High
₹1,929 - ₹2,009
52 Week Low - High
₹1,275.5 - ₹2,284.8

Glenmark Pharmaceuticals Ltd Historical Returns

1 Month Return
-7.52 %
3 Month Return
+ 26.74 %
1 Year Return
+ 13.71 %
3 Year Return
+ 416.57 %
5 Year Return
+ 291.95 %

Glenmark Pharmaceuticals Ltd Fundamentals

as on September 3, 2025 at 4:01 pm IST

Market Cap

₹54,148.69 Cr

Return on Equity (ROE)

6.78

PE Ratio (TTM)

71.87

Return on capital employed (ROCE)

8.94

Industry PE ratio

42.24

Beta (LTM)

0.66

P/B Ratio

1.18

Dividend Yield

0.26

PEG Ratio

0.98

Quarterly Earnings Growth YOY

-86.2

EPS (TTM)

37.11

Sector

Pharmaceuticals

Book Value

313.6

Technical Analysis

Bullish

View Technical Analysis

Glenmark Pharmaceuticals Ltd Stock Valuation

as on September 3, 2025 at 4:01 pm IST

Glenmark Pharmaceuticals Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-275.05x)

December 28, 2023

Industry (42.24x)

September 2, 2025

Today (71.87x)

September 2, 2025

Highest (95.94x)

September 14, 2023

LowHigh

Today’s Price to Earnings Ratio: 71.87x

Glenmark Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Glenmark Pharmaceuticals Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Glenmark Pharmaceuticals Ltd image
Glenmark Pharmaceuticals Ltd
BUY54,148.6958.39%0.591,04713,321
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
BUY34,798.3134.37%0.682641,197
Jubilant Pharmova Ltd image
Jubilant Pharmova Ltd
BUY16,551.279.24%0.718367,234
Sun Pharma Advanced Research Company Ltd image
Sun Pharma Advanced Research Company Ltd
NA4,657.53-4.08%1.88-34371
Rainbow Childrens Medicare Ltd image
Rainbow Childrens Medicare Ltd
BUY15,296.8446.91%0.672441,515
See all

Analyst Recommendation on Glenmark Pharmaceuticals Ltd Stock

Based on 11 analysts

BUY

88.89%

Buy

0.00%

Hold

11.11%

Sell

Based on 11 analysts, 88.89% of analysts recommend a 'BUY' rating for Glenmark Pharmaceuticals Ltd. Average target price of ₹2187.36

Source: S&P Global Market Intelligence

Glenmark Pharmaceuticals Ltd Share Price Target

Get share price movements and forecasts by analysts on Glenmark Pharmaceuticals Ltd.

What analysts predicted

14%UPSIDE

Target Price

₹2187.36

Current Price

₹2004.4

Analyzed by

11 Analysts

High

₹2934

Target

₹2187.36

Low

₹1500

Glenmark Pharmaceuticals Ltd target price ₹2187.36, a slight upside of 14% compared to current price of ₹2004.4. According to 11 analysts rating.

Source: S&P Global Market Intelligence

Glenmark Pharmaceuticals Ltd Stock's Interest Amongst Investors

Search interest for Glenmark Pharmaceuticals Ltd Stock has decreased by -72% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-72% versus previous 30 day period

Glenmark Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
2,982.63
3,062.75
2,958.37
2,998.47
3,160.69
2,460.29
3,016.01
3,223.3
3,400.5
3,301.9
3,220.13
3,059.33
Other Income
86.36
209.43
103.93
19.72
120.43
164.18
797.54
31.49
39.42
31.13
11.69
26.44
Total Income
3,104.29
3,309.61
3,104.45
3,055.79
3,327.81
2,670.88
3,860.49
3,275.68
3,473.21
3,418.68
3,267.89
3,290.88
Expenses
2,538.96
2,626.15
3,402.33
2,650.74
3,070.52
2,792.07
3,005.39
2,655.97
2,831.88
2,787.32
3,068
3,007.15
Operating Profit
443.67
436.6
-443.96
347.73
90.17
-331.78
10.62
567.33
568.62
514.58
152.13
52.18
Operating Profit Margin %
14.88%
14.26%
-15.01%
11.6%
2.85%
-13.49%
0.35%
17.6%
16.72%
15.58%
4.72%
1.71%
Profit Before Interest, Tax and Depreciation
565.33
683.47
-297.89
405.05
257.3
-121.2
855.1
619.71
641.33
631.36
199.89
283.73
Interest
82.94
97.11
109.14
111.61
121.46
134.34
148.56
39.58
48.48
52.29
66.71
58.23
Depreciation
145.77
151.51
135.02
142.04
141.45
147.08
151.34
117.79
120.28
122.74
125.21
129.93
Profit Before Tax
336.62
434.85
-542.05
151.4
-5.61
-402.62
555.2
462.34
472.57
456.33
7.97
95.57
Tax Paid
57.95
144.08
-138.91
-21.73
55.95
-71.8
1,769.47
122.09
118.09
108.29
3.59
48.6
Profit After Tax
278.67
290.76
-403.14
173.13
-61.56
-330.82
-1,214.27
340.24
354.49
348.03
4.38
46.97
Total Net profit including share of profit / Loss from associate company
278.67
290.76
-403.14
173.13
-61.56
-330.82
-1,214.27
340.24
354.49
348.03
4.38
46.97
EPS
9.23
9.66
-15.18
5.31
-2.9
-12.45
-43.17
12.06
12.55
12.33
0.16
1.66
Actual EPS
9.23
9.66
-15.18
5.31
-2.9
-12.45
-43.17
12.06
12.55
12.33
0.16
1.66
Adjusted EPS
9.23
9.66
-15.18
5.31
-2.9
-12.45
-43.17
12.06
12.55
12.33
0.16
1.66
Diluted EPS
9.23
9.66
-15.18
5.31
-2.9
-12.45
-43.17
12.06
12.55
12.33
0.16
1.66

Glenmark Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
8,970.09
8,972.23
9,705.08
10,397.23
10,806.03
12,174.2
11,431.94
11,635.46
13,145.84
Other Income
37.37
91.4
375.32
192.48
94.76
166.67
755.86
1,237.32
113.72
Total Income
9,223.05
9,194.47
10,240.79
10,833.45
11,038.69
12,471.58
12,339.1
13,050.42
13,435.46
Expenses
7,229.93
7,487.7
8,279.67
8,942.89
8,859.55
10,245.52
10,714.08
11,518.72
11,343.18
Operating Profit
1,740.16
1,484.53
1,425.41
1,454.34
1,946.48
1,928.68
717.86
116.74
1,802.66
Operating Profit Margin %
19.4%
16.55%
14.69%
13.99%
18.01%
15.84%
6.28%
1%
13.71%
Profit Before Interest, Tax and Depreciation
1,993.12
1,706.77
1,961.12
1,890.56
2,179.14
2,226.06
1,625.01
1,531.7
2,092.28
Interest
237.32
285.57
334.59
377.32
353.11
298.1
349.04
515.97
207.07
Depreciation
264.37
301.88
325.91
417.17
443.55
486.72
569.17
581.91
486.01
Profit Before Tax
1,491.43
1,119.32
1,300.62
1,096.07
1,382.48
1,441.24
706.8
433.82
1,399.2
Tax Paid
382.67
315.46
375.63
320.11
412.39
447.6
329.4
1,867.34
352.07
Profit After Tax
1,108.75
803.87
924.99
775.97
970.09
993.65
377.4
-1,433.52
1,047.14
Total Net profit including share of profit / Loss from associate company
1,108.75
803.87
924.99
775.97
970.09
993.65
377.4
-1,433.52
1,047.14
EPS
39.29
28.49
32.78
27.5
34.38
33.37
10.53
-53.22
37.11
Actual EPS
39.29
28.49
32.78
27.5
34.38
33.37
10.53
-53.22
37.11
Adjusted EPS
39.29
28.49
32.78
27.5
34.38
33.37
10.53
-53.22
37.11
Diluted EPS
39.28
28.49
32.78
27.5
34.38
33.37
10.53
-53.22
37.1

Glenmark Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2015
Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Net Cash from Operating Activities
481.68
344.85
657.43
1,648.05
1,324.17
1,392.41
1,131.21
1,108.65
625.39
-265.44
Cash Flow from Investing Activities
-711.96
-950.06
-1,001.34
-1,002.56
-882.52
-773.75
-661.62
-315.74
-515.43
4,386.81
Cash Flow from Financing Activities
199.22
698.6
543.14
-468.49
-738.74
-444.65
-441.78
-463.11
75.27
-3,906.13
Net Cash Flow
-31.06
93.39
199.24
176.99
-297.08
174
27.82
272.43
32.5
215.24

Glenmark Pharmaceuticals Ltd Stock Shareholding Pattern

Numbers in percentages

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Promoters
46.65%
46.65%
46.65%
46.65%
46.65%
46.65%
46.64%
46.65%
46.65%
46.65%
46.65%
46.65%
DII
10.64%
10.69%
10.41%
9.11%
10.32%
10.92%
13.36%
13.92%
13.21%
13.85%
14.6%
17.64%
FII
0%
0%
0%
0%
24.8%
23.71%
21.38%
20.98%
23.05%
23.51%
23.16%
20.62%
Government
0.04%
0.04%
0.04%
0.04%
0.04%
0.04%
0.04%
0.04%
0.04%
0.04%
0.04%
0.04%
Public
19.27%
19.43%
20.45%
18.68%
18.2%
18.69%
18.58%
18.41%
17.06%
15.96%
15.56%
15.06%
Total Outstanding Shares
28,21,68,156
28,21,68,156
28,21,68,156
28,21,68,156
28,21,68,156
28,21,68,156
28,21,88,156
28,21,88,156
28,21,88,156
28,21,88,156
28,21,88,156
28,22,00,809
Total Shareholders
3,13,540
3,00,106
2,85,461
2,36,908
2,32,685
2,09,931
1,99,451
1,92,630
1,93,949
1,95,059
1,92,724
1,90,210

Mutual Funds that own Glenmark Pharmaceuticals Ltd Stock

Check out the Mutual Funds with significant holdings in Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Glenmark Pharmaceuticals Ltd.

  • Glenmark Pharmaceuticals Ltd Earnings Results

    Glenmark Pharmaceuticals Ltd’s net profit fell -86.23% since last year same period to ₹46.87Cr in the Q1 2025-2026. On a quarterly growth basis, Glenmark Pharmaceuticals Ltd has generated 907.96% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Glenmark Pharmaceuticals Ltd Dividends May,2024

    In the quarter ending March 2024, Glenmark Pharmaceuticals Ltd has declared dividend of ₹2.50 per share on 24 May 2024 - translating a dividend yield of 0.13%.

    Read More about Dividends

Indices Featuring Glenmark Pharmaceuticals Ltd Stock

Check stock indices that include Glenmark Pharmaceuticals Ltd.

BSE Mid-Cap

₹45,780.69

0.63 (▲284.41%)

Nifty Healthcare

₹14,496.65

1.08 (▲154.35%)

Nifty Alpha 50

₹50,892.70

1.17 (▲587%)

Nifty Midcap 150

₹21,292.25

0.67 (▲142.55%)

S&P BSE 400 MidSmallCap

₹11,981.88

0.68 (▲80.53%)

NIFTY PHARMA

₹21,959.60

1.1 (▲239.65%)

S&P BSE 150 MidCap

₹15,942.78

0.63 (▲100.52%)

BSE Healthcare

₹44,249.52

1.2 (▲522.82%)

S&P BSE 250 LargeMidCap

₹10,666.63

0.57 (▲60.93%)

BSE 500

₹35,905.15

0.59 (▲211.53%)

Nifty 500

₹22,864.65

0.62 (▲140.25%)

Nifty Midcap 100

₹57,345.50

0.65 (▲368.1%)

S&P BSE Momentum

₹2,215.75

1.04 (▲22.89%)

Nifty MidSmallcap 400

₹19,751.75

0.73 (▲143.55%)

Nifty 200

₹13,802.00

-2.05 (▲-289.27%)

Nifty LargeMidcap 250

₹16,062.35

0.62 (▲99.35%)

Insights on Glenmark Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 12.86% to 15.55% in Jun 2025 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 3.26K Cr → 3.29K Cr (in ₹), with an average increase of 0.7% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 4.65 Cr → 46.87 Cr (in ₹), with an average increase of 90.1% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, GLENMARK has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, GLENMARK stock has moved up by 416.6%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 46.65% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 20.8% return, outperforming this stock by 7.1%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 23.16% to 20.62% in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 15.56% to 15.06% in Jun 2025 quarter

About Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd is an Indian pharmaceuticals company listed on the National Stock Exchange and Bombay Stock Exchange. Established in 1977, the company manufactures and distributes branded and generic formulations, active pharmaceutical ingredients (API’s) and biosimilars. It has 18 manufacturing facilities in India, 7 in the U.S., 1 in Brazil and 1 in Mexico that span across the world catering to global requirements. Glenmark has taken several steps towards achieving a healthy presence in the global markets. In addition to its product portfolio, Glenmark’s aggressive acquisition strategy and product launch activities have helped expand its market reach. The company has been awarded numerous accolades over the years, including consecutive years of being ranked amongst the top 1000 world pharmaceutical companies. It continues to be a frontrunner in providing quality and affordable healthcare solutions in India and abroad.

Revenue: ₹3,059.33Cr as on June 2025 (Q1 FY26)
Net Profit: ₹46.97Cr as on June 2025 (Q1 FY26)
Listing date: 07 Feb, 2000
Chairperson Name: Glenn Saldanha
OrganisationGlenmark Pharmaceuticals Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOGlenn Saldanha
E-voting on sharesClick here to vote

FAQs

What is Glenmark Pharmaceuticals Ltd share price today?

Glenmark Pharmaceuticals Ltd share price today stands at ₹2004.4 as on at the close of the market. Glenmark Pharmaceuticals Ltd share today touched a day high of ₹2009 and a low of ₹1929.

What is the 52 week high and 52 week low range for Glenmark Pharmaceuticals Ltd share?

Glenmark Pharmaceuticals Ltd touched a 52 week high of ₹2284.8 and a 52 week low of ₹1275.5. Glenmark Pharmaceuticals Ltd share price today i.e. is closed at ₹2004.4, which is -12.27% down from its 52 week high and 57.15% up from its 52 week low.

What is Glenmark Pharmaceuticals Ltd's market capitalisation today?

Glenmark Pharmaceuticals Ltd market capitalisation is ₹54,148.69 Cr as on .

How to buy Glenmark Pharmaceuticals Ltd shares?

To buy Glenmark Pharmaceuticals Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for GLENMARK or Glenmark Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Glenmark Pharmaceuticals Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Glenmark Pharmaceuticals Ltd trading volume today?

Glenmark Pharmaceuticals Ltd trading volume is 13.82L as on . This means that 13.82L shares of Glenmark Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.